ConsultantLive Members: Login | Register
 |  |
ConsultantLive SearchMedica Medline Drugs

Powered by SearchMedica

 
About Us
Blogs
Dermclinic
Photoclinic
Pediatric Center
Multimedia
Topics
What's Your Diagnosis?
 

Home »

Consultant. Vol. 49 No. 10
Pages: 1  2  
Next
 

Allergic Rhinitis: Update on Diagnosis

By ROBERT S. VALET, MD and JOHN M. FAHRENHOLZ, MD — Vanderbilt University | October 1, 2009
Dr Valet is a research fellow at the Institute of Medicine and Public Health at Vanderbilt University School of Medicine in Nashville, Tenn. Dr Fahrenholz is assistant professor of medicine in the division of allergy, pulmonary, and critical care medicine at Vanderbilt University School of Medicine.

ABSTRACT: Allergic rhinitis is a common disorder that greatly affects patients' quality of life and has high costs related to treatment expenses and lost productivity. Rhinitis may be allergic or nonallergic. Pure allergic rhinitis is about 3 times more prevalent than pure nonallergic rhinitis; however, many patients have both types. Other conditions, particularly structural problems within the nose such as nasal septal deviation and polyps, can cause rhinitis symptoms. The history typically focuses on symptoms associated with allergic rhinitis in the nose (congestion, rhinorrhea, pruritus), eyes (itching, redness), and ears (congestion). For patients with compatible history and physical findings, initial empiric therapy is appropriate. Confirmatory skin tests or in vitro allergy tests can be undertaken for further diagnostic certainty or to facilitate avoidance of or immunotherapy against particular allergens in select patients.

Key words: allergic rhinitis, nonallergic rhinitis, primary care



Allergic rhinitis is highly prevalent; about 20% of adults in the United States1 and 25% of children worldwide2 are affected. It is a major societal expense, with direct costs, attributable to physician visits and medications, of up to $5 billion per year, and indirect costs, mainly stemming from lost productivity, of up to $9.7 billion per year.3 In the United States, allergic rhinitis results in 3.5 million lost workdays and 2 million lost schooldays each year.4

In addition to the nasal and ocular symptoms of the disease, allergic rhinitis is associated with a higher burden of asthma and sinusitis.5 It also affects multiple areas related to quality of life, including quality of sleep,6,7 mood and energy level,4 work effectiveness,8 and even sexual function.9

Because nearly all patients with allergic rhinitis who seek medical attention present first to their primary care physician,1 this 2-part series will focus on the diagnosis and management of allergic rhinitis in the primary care setting. Here we discuss issues related to diagnosis, including the various types of rhinitis, complicating factors, common physical findings, and allergy` testing. In a coming issue, we will detail the treatment options.

ALLERGIC VERSUS NONALLERGIC RHINITIS

While the term “rhinitis” suggests that inflammation of the upper airway would be a cardinal feature, some forms of rhinitis do not involve inflammation. Rather, the term refers to the presence of one or more of the following10:

• Nasal congestion.
• Pruritus.
• Sneezing.
• Anterior or posterior rhinorrhea.

Causes of rhinitis are divided most broadly into allergic and nonallergic (Table).1,10,11

Allergic rhinitis. The usual onset is before age 20. Allergic rhinitis is caused by an IgE-mediated reaction to specific seasonal or perennial aeroallergens.11 Since the indoor environment is relatively invariant, associated allergens (most commonly dust mite, mold, pet dander, and cockroach) cause perennial symptoms. Outdoor allergens, including pollens, mold, and bioaerosols such as those from grass cutting (which can also function as nonallergic irritants), tend to cause seasonal symptoms, although there is regional variability because certain pollens have a seasonal presence in some areas but are present year-round in other areas.10

In allergic rhinitis, specific IgE antibodies to allergens develop and are displayed on the surface of mast cells. When allergen binds the mast cell–bound antibody, the mast cells release cytokines, leading within minutes to an early response that consists of sneezing, itchiness, congestion, rhinorrhea, and even constitutional symptoms (hence the term “hay fever”). These cytokines also attract other inflammatory cells to the nasal mucosa, in what is referred to as the second, or late-phase, allergic rhinitis response, which prominently features nasal congestion.12

Nonallergic rhinitis. This type of rhinitis does not involve IgE. Pure allergic rhinitis is thought to be about 3 times more prevalent than pure nonallergic rhinitis; however, a mixed picture of the two is quite common: it is estimated that 44% to 87% of patients with rhinitis have some component of mixed rhinitis.10 Nonallergic rhinitis has a slight female predominance and has a later age of onset, generally in adulthood, than allergic rhinitis.13

There are several subtypes of nonallergic rhinitis. Vasomotor rhinitis is an incompletely understood entity thought to involve neurally mediated hypersecretion and hyperemia in the nasal mucosa; it is ultimately a diagnosis of exclusion in patients whose allergy test results are negative.10,13,14 Triggers for this subtype include exercise, changes in temperature or humidity, alcohol(Drug information on alcohol) ingestion, and inhaled irritants, such as tobacco smoke, perfume, and chlorine gas.13

Gustatory rhinitis refers to rhinorrhea induced by eating; it is thought to be vagally mediated and not allergic. Although allergic reactions to food can induce rhinitis, such reactions are almost always seen in concert with an urticarial rash, respiratory symptoms, and/or GI symptoms.15 Gustatory rhinitis generally occurs in older patients, most commonly in reaction to spicy foods, but some patients have rhinorrhea in response to a wide range of foods.16

Drug-induced rhinitis can occur with the use of a number of medications, including angiotensin-converting enzyme (ACE) inhibitors, hydrochlorothiazide(Drug information on hydrochlorothiazide),β-blockers, α1-blockers, central α2-agonists, and phosphodiesterase-5 inhibitors.13 When related to rebound congestion from overuse of nasal α-adrenergic agonists such as oxymetazoline(Drug information on oxymetazoline), the syndrome is referred to as rhinitis medicamentosa.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Asthma

Atrial Fibrillation

Cardiovascular

Cerebrovascular

Developmental/Genetic

Diabetes

Diabetes Type 2

Fibromyalgia

Geriatrics

GI Disorders

Gout

Health Care Reform

HIV/AIDS

Hypertension

Infection

Mental Health

 

Musculoskeletal

Nervous System

Nutritional/Metabolic 

Otorhinolaryngologic 

Pain

Pediatrics

Physical Abuse

Respiratory Tract 

Rheumatic Diseases

Seasonal Allergies

Skin Diseases

Sleep Disorders

Urologic Diseases

Vaccines

Women’s Health

All Topics

 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Painful Red Ear
  • Facial Skin Problems—A Photo Essay
  • Scaly Plaque on the Nose
  • Go For The Glory Quiz: Persistent Oral Lesions, Nevus or Melanoma?, Altered Mental Status in Middle Age, An Itchy, Scaly Rash, Painful Blisters of the Hand
  • T-Wave Inversions: Sorting Through the Causes
  • Tuberculosis Diagnosis With Handheld Device
  • Physician, First Do No Harm—To Yourself
  • Making the Most of Antihypertensive Drug Combinations
  • Superficial Abrasion After a Fall From a Bicycle
  • A Requiem for Beta Blockers to Treat Hypertension?
  • New Sunscreen Labels Decoded, But Are Sunscreens Safe?
  • Women Underrepresented in Antiretroviral Clinical Trials
  • Crohn Disease: New Scoring System Predicts Mild Disease
  • Iron deficiency Anemia in IBD: These Patients Need Primary Care
  • Statins Plus Exercise: New Study Questions the Combination
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Nodular Basal Cell Carcinoma
  • Short on Physicians, Long on Adverse Effects
  • Wanted: Physician Feedback on Medical Cannabis
  • Why Doctors Commit Suicide
  • Crusted Scabies
  • Scaly Plaque on the Nose
  • Short on Physicians, Long on Adverse Effects
  • Furuncle Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
  • Resistant Hypertension: Four Pearls for Your Practice
  • Nodular Basal Cell Carcinoma
Click here to subscribe to our newsletter


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy